Table 1.
Staging system | Size | Nodules | Met | PVT | AFP | CH | Alb | Bil | ALP | Ascites | PS |
TNM | Yes | Yes | Yes | No | No | No | No | No | No | No | No |
Okuda | Yes | No | No | No | No | No | Yes | Yes | No | Yes | No |
CLIP | Yes | No | No | Yes | Yes | Yes | No | No | No | No | No |
FRENCH | No | No | No | Yes | Yes | No | No | Yes | Yes | No | Yes |
BCLC | Yes | Yes | Yes | Yes | No | Yes | No | Yes | No | No | Yes |
JIS | Yes | Yes | Yes | No | No | Yes | No | No | No | No | No |
CUPI | Yes | Yes | Yes | No | Yes | No | No | Yes | Yes | Yes | No |
Met: Metastasis; PVT: Portal vein thrombosis; AFP: Alfafetoproteina; Alb: Albumin; Bil: Bilirubin; ALP: Alkaline phosphatise; PS: Performance status; CLIP: Cancer of the Liver Italian Program; BCLC: Barcelona clinic liver cancer classification; CUPI: Chinese University Prognosis Index; JIS: The Japan Integrated Staging; TNM: Classification of malignant tumours; FRENCH: French classification of hepatocellular carcinomas; CH: Child-Pugh.